ArticleBMC infectious diseases2025
Tuberculosis treatment outcomes and associated factors among patients on anti- TB treatment in Nekemte public health facilities, oromia regional State, Western Ethiopia.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTuberculosis (TB) has been recognized as one of the major public health problems in Ethiopia over the past 50 years. It is the leading cause of morbidity, the third leading cause of hospitalization, and the second leading cause of death. Successful treatment outcomes are crucial in order to improve the Tuberculosis management program. This study is aimed to assess treatment outcomes of TB and the factors that influence the observed treatment outcomes in TB patients of Nekemte public health facility.
methodAn institutional-based cross-sectional study design was conducted in Nekemte town public health care facilities from November 1 to November 30, 2021. The data were collected by using a checklist from TB registration logbook, patient medical cards, and laboratory requests. The data was entered into Epi data version 3.1 and analyzed using SPSS version 24. The variables associated with the treatment outcomes were selected using bivariable and multivariable logistic regression analysis. The level of significance was expressed by the adjusted odds ratio (AOR) with a 95% confidence interval (CI). A variable with a p-value less than 0.05 was considered statistically significant.
resultSuccessful treatment outcomes of the TB patients were 77.3% (95%CI: 74.6, 79.8). Urban residency (AOR = 2.8, 95% CI: 1.8-4.34), absence previous treatment history (AOR = 3.5, 95% CI: 1.34-9.164), absence of history of comorbidity (AOR = 13.9, 95% CI:7.1-27.33), and patients who had DOTs supporter (AOR = 7.7, 95% CI: 3.9 -15.11) were significantly associated with successful TB treatment outcomes. CONCLUSION AND RECOMMENDATION: The study found that TB treatment success rates were below national and global targets. Factors such as urban residency, absence of previous TB treatment, absence of comorbidity, DOTs supporter was found to be the significant predictors of TB treatment outcome. To improve success rates, it is recommended to expand access to trained DOTs supporters, particularly in rural areas, and prioritize monitoring of high-risk populations, including patients with a history of TB treatment, additionally, educate family members on supporting treatment adherence and addressing co-morbidities through integrated care models will contribute to improved treatment adherence and success.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.